Global Anti Obesity Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Anti Obesity Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Anti Obesity Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Anti Obesity Drugs by Country/Region, 2017, 2022 & 2028

2.2 Anti Obesity Drugs Segment by Type

2.2.1 Oral Medicine

2.2.2 Diet Patch

2.2.3 Other

2.3 Anti Obesity Drugs Sales by Type

2.3.1 Global Anti Obesity Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Anti Obesity Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Anti Obesity Drugs Sale Price by Type (2017-2022)

2.4 Anti Obesity Drugs Segment by Application

2.4.1 Men

2.4.2 Women

2.5 Anti Obesity Drugs Sales by Application

2.5.1 Global Anti Obesity Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Anti Obesity Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Anti Obesity Drugs Sale Price by Application (2017-2022)

3 Global Anti Obesity Drugs by Company

3.1 Global Anti Obesity Drugs Breakdown Data by Company

3.1.1 Global Anti Obesity Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Anti Obesity Drugs Sales Market Share by Company (2020-2022)

3.2 Global Anti Obesity Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Anti Obesity Drugs Revenue by Company (2020-2022)

3.2.2 Global Anti Obesity Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Anti Obesity Drugs Sale Price by Company

3.4 Key Manufacturers Anti Obesity Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Anti Obesity Drugs Product Location Distribution

3.4.2 Players Anti Obesity Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Anti Obesity Drugs by Geographic Region

4.1 World Historic Anti Obesity Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Anti Obesity Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Anti Obesity Drugs Annual Revenue by Geographic Region

4.2 World Historic Anti Obesity Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Anti Obesity Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Anti Obesity Drugs Annual Revenue by Country/Region

4.3 Americas Anti Obesity Drugs Sales Growth

4.4 APAC Anti Obesity Drugs Sales Growth

4.5 Europe Anti Obesity Drugs Sales Growth

4.6 Middle East & Africa Anti Obesity Drugs Sales Growth

5 Americas

5.1 Americas Anti Obesity Drugs Sales by Country

5.1.1 Americas Anti Obesity Drugs Sales by Country (2017-2022)

5.1.2 Americas Anti Obesity Drugs Revenue by Country (2017-2022)

5.2 Americas Anti Obesity Drugs Sales by Type

5.3 Americas Anti Obesity Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Anti Obesity Drugs Sales by Region

6.1.1 APAC Anti Obesity Drugs Sales by Region (2017-2022)

6.1.2 APAC Anti Obesity Drugs Revenue by Region (2017-2022)

6.2 APAC Anti Obesity Drugs Sales by Type

6.3 APAC Anti Obesity Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Anti Obesity Drugs by Country

7.1.1 Europe Anti Obesity Drugs Sales by Country (2017-2022)

7.1.2 Europe Anti Obesity Drugs Revenue by Country (2017-2022)

7.2 Europe Anti Obesity Drugs Sales by Type

7.3 Europe Anti Obesity Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Anti Obesity Drugs by Country

8.1.1 Middle East & Africa Anti Obesity Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Anti Obesity Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Anti Obesity Drugs Sales by Type

8.3 Middle East & Africa Anti Obesity Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Anti Obesity Drugs

10.3 Manufacturing Process Analysis of Anti Obesity Drugs

10.4 Industry Chain Structure of Anti Obesity Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Anti Obesity Drugs Distributors

11.3 Anti Obesity Drugs Customer

12 World Forecast Review for Anti Obesity Drugs by Geographic Region

12.1 Global Anti Obesity Drugs Market Size Forecast by Region

12.1.1 Global Anti Obesity Drugs Forecast by Region (2023-2028)

12.1.2 Global Anti Obesity Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Anti Obesity Drugs Forecast by Type

12.7 Global Anti Obesity Drugs Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Anti Obesity Drugs Product Offered

13.1.3 Pfizer Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 Merck

13.2.1 Merck Company Information

13.2.2 Merck Anti Obesity Drugs Product Offered

13.2.3 Merck Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Main Business Overview

13.2.5 Merck Latest Developments

13.3 Roche

13.3.1 Roche Company Information

13.3.2 Roche Anti Obesity Drugs Product Offered

13.3.3 Roche Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Roche Main Business Overview

13.3.5 Roche Latest Developments

13.4 GlaxoSmithKline

13.4.1 GlaxoSmithKline Company Information

13.4.2 GlaxoSmithKline Anti Obesity Drugs Product Offered

13.4.3 GlaxoSmithKline Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 GlaxoSmithKline Main Business Overview

13.4.5 GlaxoSmithKline Latest Developments

13.5 AstraZeneca

13.5.1 AstraZeneca Company Information

13.5.2 AstraZeneca Anti Obesity Drugs Product Offered

13.5.3 AstraZeneca Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 AstraZeneca Main Business Overview

13.5.5 AstraZeneca Latest Developments

13.6 Boehringer Ingelheim

13.6.1 Boehringer Ingelheim Company Information

13.6.2 Boehringer Ingelheim Anti Obesity Drugs Product Offered

13.6.3 Boehringer Ingelheim Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Boehringer Ingelheim Main Business Overview

13.6.5 Boehringer Ingelheim Latest Developments

13.7 Novo Nordisk

13.7.1 Novo Nordisk Company Information

13.7.2 Novo Nordisk Anti Obesity Drugs Product Offered

13.7.3 Novo Nordisk Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Novo Nordisk Main Business Overview

13.7.5 Novo Nordisk Latest Developments

13.8 Eisai

13.8.1 Eisai Company Information

13.8.2 Eisai Anti Obesity Drugs Product Offered

13.8.3 Eisai Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Eisai Main Business Overview

13.8.5 Eisai Latest Developments

13.9 Norgine

13.9.1 Norgine Company Information

13.9.2 Norgine Anti Obesity Drugs Product Offered

13.9.3 Norgine Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Norgine Main Business Overview

13.9.5 Norgine Latest Developments

13.10 Arena Pharmaceuticals

13.10.1 Arena Pharmaceuticals Company Information

13.10.2 Arena Pharmaceuticals Anti Obesity Drugs Product Offered

13.10.3 Arena Pharmaceuticals Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Arena Pharmaceuticals Main Business Overview

13.10.5 Arena Pharmaceuticals Latest Developments

13.11 Orexigen Therapeutics

13.11.1 Orexigen Therapeutics Company Information

13.11.2 Orexigen Therapeutics Anti Obesity Drugs Product Offered

13.11.3 Orexigen Therapeutics Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Orexigen Therapeutics Main Business Overview

13.11.5 Orexigen Therapeutics Latest Developments

13.12 Vivus

13.12.1 Vivus Company Information

13.12.2 Vivus Anti Obesity Drugs Product Offered

13.12.3 Vivus Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Vivus Main Business Overview

13.12.5 Vivus Latest Developments

13.13 Alizyme

13.13.1 Alizyme Company Information

13.13.2 Alizyme Anti Obesity Drugs Product Offered

13.13.3 Alizyme Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Alizyme Main Business Overview

13.13.5 Alizyme Latest Developments

13.14 Rhythm Pharmaceuticals

13.14.1 Rhythm Pharmaceuticals Company Information

13.14.2 Rhythm Pharmaceuticals Anti Obesity Drugs Product Offered

13.14.3 Rhythm Pharmaceuticals Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Rhythm Pharmaceuticals Main Business Overview

13.14.5 Rhythm Pharmaceuticals Latest Developments

13.15 Shionogi

13.15.1 Shionogi Company Information

13.15.2 Shionogi Anti Obesity Drugs Product Offered

13.15.3 Shionogi Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Shionogi Main Business Overview

13.15.5 Shionogi Latest Developments

13.16 Zafgan

13.16.1 Zafgan Company Information

13.16.2 Zafgan Anti Obesity Drugs Product Offered

13.16.3 Zafgan Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Zafgan Main Business Overview

13.16.5 Zafgan Latest Developments

14 Research Findings and Conclusion

Table 1. Anti Obesity Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Anti Obesity Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Oral Medicine

Table 4. Major Players of Diet Patch

Table 5. Major Players of Other

Table 6. Global Anti Obesity Drugs Sales by Type (2017-2022) & (K Units)

Table 7. Global Anti Obesity Drugs Sales Market Share by Type (2017-2022)

Table 8. Global Anti Obesity Drugs Revenue by Type (2017-2022) & ($ million)

Table 9. Global Anti Obesity Drugs Revenue Market Share by Type (2017-2022)

Table 10. Global Anti Obesity Drugs Sale Price by Type (2017-2022) & (USD/Units)

Table 11. Global Anti Obesity Drugs Sales by Application (2017-2022) & (K Units)

Table 12. Global Anti Obesity Drugs Sales Market Share by Application (2017-2022)

Table 13. Global Anti Obesity Drugs Revenue by Application (2017-2022)

Table 14. Global Anti Obesity Drugs Revenue Market Share by Application (2017-2022)

Table 15. Global Anti Obesity Drugs Sale Price by Application (2017-2022) & (USD/Units)

Table 16. Global Anti Obesity Drugs Sales by Company (2020-2022) & (K Units)

Table 17. Global Anti Obesity Drugs Sales Market Share by Company (2020-2022)

Table 18. Global Anti Obesity Drugs Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Anti Obesity Drugs Revenue Market Share by Company (2020-2022)

Table 20. Global Anti Obesity Drugs Sale Price by Company (2020-2022) & (USD/Units)

Table 21. Key Manufacturers Anti Obesity Drugs Producing Area Distribution and Sales Area

Table 22. Players Anti Obesity Drugs Products Offered

Table 23. Anti Obesity Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Anti Obesity Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Anti Obesity Drugs Sales Market Share Geographic Region (2017-2022)

Table 28. Global Anti Obesity Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Anti Obesity Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Anti Obesity Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Anti Obesity Drugs Sales Market Share by Country/Region (2017-2022)

Table 32. Global Anti Obesity Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Anti Obesity Drugs Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Anti Obesity Drugs Sales by Country (2017-2022) & (K Units)

Table 35. Americas Anti Obesity Drugs Sales Market Share by Country (2017-2022)

Table 36. Americas Anti Obesity Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Anti Obesity Drugs Revenue Market Share by Country (2017-2022)

Table 38. Americas Anti Obesity Drugs Sales by Type (2017-2022) & (K Units)

Table 39. Americas Anti Obesity Drugs Sales Market Share by Type (2017-2022)

Table 40. Americas Anti Obesity Drugs Sales by Application (2017-2022) & (K Units)

Table 41. Americas Anti Obesity Drugs Sales Market Share by Application (2017-2022)

Table 42. APAC Anti Obesity Drugs Sales by Region (2017-2022) & (K Units)

Table 43. APAC Anti Obesity Drugs Sales Market Share by Region (2017-2022)

Table 44. APAC Anti Obesity Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Anti Obesity Drugs Revenue Market Share by Region (2017-2022)

Table 46. APAC Anti Obesity Drugs Sales by Type (2017-2022) & (K Units)

Table 47. APAC Anti Obesity Drugs Sales Market Share by Type (2017-2022)

Table 48. APAC Anti Obesity Drugs Sales by Application (2017-2022) & (K Units)

Table 49. APAC Anti Obesity Drugs Sales Market Share by Application (2017-2022)

Table 50. Europe Anti Obesity Drugs Sales by Country (2017-2022) & (K Units)

Table 51. Europe Anti Obesity Drugs Sales Market Share by Country (2017-2022)

Table 52. Europe Anti Obesity Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Anti Obesity Drugs Revenue Market Share by Country (2017-2022)

Table 54. Europe Anti Obesity Drugs Sales by Type (2017-2022) & (K Units)

Table 55. Europe Anti Obesity Drugs Sales Market Share by Type (2017-2022)

Table 56. Europe Anti Obesity Drugs Sales by Application (2017-2022) & (K Units)

Table 57. Europe Anti Obesity Drugs Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Anti Obesity Drugs Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Anti Obesity Drugs Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Anti Obesity Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Anti Obesity Drugs Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Anti Obesity Drugs Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Anti Obesity Drugs Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Anti Obesity Drugs Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Anti Obesity Drugs Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Anti Obesity Drugs

Table 67. Key Market Challenges & Risks of Anti Obesity Drugs

Table 68. Key Industry Trends of Anti Obesity Drugs

Table 69. Anti Obesity Drugs Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Anti Obesity Drugs Distributors List

Table 72. Anti Obesity Drugs Customer List

Table 73. Global Anti Obesity Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Anti Obesity Drugs Sales Market Forecast by Region

Table 75. Global Anti Obesity Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Anti Obesity Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Anti Obesity Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Anti Obesity Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Anti Obesity Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Anti Obesity Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Anti Obesity Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Anti Obesity Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Anti Obesity Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Anti Obesity Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Anti Obesity Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Anti Obesity Drugs Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Anti Obesity Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Anti Obesity Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Anti Obesity Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Anti Obesity Drugs Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Anti Obesity Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Anti Obesity Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 93. Pfizer Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 94. Pfizer Anti Obesity Drugs Product Offered

Table 95. Pfizer Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 96. Pfizer Main Business

Table 97. Pfizer Latest Developments

Table 98. Merck Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 99. Merck Anti Obesity Drugs Product Offered

Table 100. Merck Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 101. Merck Main Business

Table 102. Merck Latest Developments

Table 103. Roche Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 104. Roche Anti Obesity Drugs Product Offered

Table 105. Roche Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 106. Roche Main Business

Table 107. Roche Latest Developments

Table 108. GlaxoSmithKline Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 109. GlaxoSmithKline Anti Obesity Drugs Product Offered

Table 110. GlaxoSmithKline Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 111. GlaxoSmithKline Main Business

Table 112. GlaxoSmithKline Latest Developments

Table 113. AstraZeneca Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 114. AstraZeneca Anti Obesity Drugs Product Offered

Table 115. AstraZeneca Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 116. AstraZeneca Main Business

Table 117. AstraZeneca Latest Developments

Table 118. Boehringer Ingelheim Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 119. Boehringer Ingelheim Anti Obesity Drugs Product Offered

Table 120. Boehringer Ingelheim Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 121. Boehringer Ingelheim Main Business

Table 122. Boehringer Ingelheim Latest Developments

Table 123. Novo Nordisk Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 124. Novo Nordisk Anti Obesity Drugs Product Offered

Table 125. Novo Nordisk Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 126. Novo Nordisk Main Business

Table 127. Novo Nordisk Latest Developments

Table 128. Eisai Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 129. Eisai Anti Obesity Drugs Product Offered

Table 130. Eisai Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 131. Eisai Main Business

Table 132. Eisai Latest Developments

Table 133. Norgine Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 134. Norgine Anti Obesity Drugs Product Offered

Table 135. Norgine Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 136. Norgine Main Business

Table 137. Norgine Latest Developments

Table 138. Arena Pharmaceuticals Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 139. Arena Pharmaceuticals Anti Obesity Drugs Product Offered

Table 140. Arena Pharmaceuticals Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 141. Arena Pharmaceuticals Main Business

Table 142. Arena Pharmaceuticals Latest Developments

Table 143. Orexigen Therapeutics Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 144. Orexigen Therapeutics Anti Obesity Drugs Product Offered

Table 145. Orexigen Therapeutics Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 146. Orexigen Therapeutics Main Business

Table 147. Orexigen Therapeutics Latest Developments

Table 148. Vivus Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 149. Vivus Anti Obesity Drugs Product Offered

Table 150. Vivus Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 151. Vivus Main Business

Table 152. Vivus Latest Developments

Table 153. Alizyme Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 154. Alizyme Anti Obesity Drugs Product Offered

Table 155. Alizyme Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 156. Alizyme Main Business

Table 157. Alizyme Latest Developments

Table 158. Rhythm Pharmaceuticals Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 159. Rhythm Pharmaceuticals Anti Obesity Drugs Product Offered

Table 160. Rhythm Pharmaceuticals Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 161. Rhythm Pharmaceuticals Main Business

Table 162. Rhythm Pharmaceuticals Latest Developments

Table 163. Shionogi Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 164. Shionogi Anti Obesity Drugs Product Offered

Table 165. Shionogi Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 166. Shionogi Main Business

Table 167. Shionogi Latest Developments

Table 168. Zafgan Basic Information, Anti Obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 169. Zafgan Anti Obesity Drugs Product Offered

Table 170. Zafgan Anti Obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 171. Zafgan Main Business

Table 172. Zafgan Latest Developments

List of Figures

Figure 1. Picture of Anti Obesity Drugs

Figure 2. Anti Obesity Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Anti Obesity Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Anti Obesity Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Anti Obesity Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Oral Medicine

Figure 10. Product Picture of Diet Patch

Figure 11. Product Picture of Other

Figure 12. Global Anti Obesity Drugs Sales Market Share by Type in 2021

Figure 13. Global Anti Obesity Drugs Revenue Market Share by Type (2017-2022)

Figure 14. Anti Obesity Drugs Consumed in Men

Figure 15. Global Anti Obesity Drugs Market: Men (2017-2022) & (K Units)

Figure 16. Anti Obesity Drugs Consumed in Women

Figure 17. Global Anti Obesity Drugs Market: Women (2017-2022) & (K Units)

Figure 18. Global Anti Obesity Drugs Sales Market Share by Application (2017-2022)

Figure 19. Global Anti Obesity Drugs Revenue Market Share by Application in 2021

Figure 20. Anti Obesity Drugs Revenue Market by Company in 2021 ($ Million)

Figure 21. Global Anti Obesity Drugs Revenue Market Share by Company in 2021

Figure 22. Global Anti Obesity Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global Anti Obesity Drugs Revenue Market Share by Geographic Region in 2021

Figure 24. Global Anti Obesity Drugs Sales Market Share by Region (2017-2022)

Figure 25. Global Anti Obesity Drugs Revenue Market Share by Country/Region in 2021

Figure 26. Americas Anti Obesity Drugs Sales 2017-2022 (K Units)

Figure 27. Americas Anti Obesity Drugs Revenue 2017-2022 ($ Millions)

Figure 28. APAC Anti Obesity Drugs Sales 2017-2022 (K Units)

Figure 29. APAC Anti Obesity Drugs Revenue 2017-2022 ($ Millions)

Figure 30. Europe Anti Obesity Drugs Sales 2017-2022 (K Units)

Figure 31. Europe Anti Obesity Drugs Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa Anti Obesity Drugs Sales 2017-2022 (K Units)

Figure 33. Middle East & Africa Anti Obesity Drugs Revenue 2017-2022 ($ Millions)

Figure 34. Americas Anti Obesity Drugs Sales Market Share by Country in 2021

Figure 35. Americas Anti Obesity Drugs Revenue Market Share by Country in 2021

Figure 36. United States Anti Obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada Anti Obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico Anti Obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil Anti Obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC Anti Obesity Drugs Sales Market Share by Region in 2021

Figure 41. APAC Anti Obesity Drugs Revenue Market Share by Regions in 2021

Figure 42. China Anti Obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan Anti Obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea Anti Obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia Anti Obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. India Anti Obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia Anti Obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe Anti Obesity Drugs Sales Market Share by Country in 2021

Figure 49. Europe Anti Obesity Drugs Revenue Market Share by Country in 2021

Figure 50. Germany Anti Obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. France Anti Obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK Anti Obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy Anti Obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia Anti Obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa Anti Obesity Drugs Sales Market Share by Country in 2021

Figure 56. Middle East & Africa Anti Obesity Drugs Revenue Market Share by Country in 2021

Figure 57. Egypt Anti Obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa Anti Obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel Anti Obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey Anti Obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country Anti Obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of Anti Obesity Drugs in 2021

Figure 63. Manufacturing Process Analysis of Anti Obesity Drugs

Figure 64. Industry Chain Structure of Anti Obesity Drugs

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles